Provided by Tiger Trade Technology Pte. Ltd.

XILIO THERAPEUTICS, INC.

0.7322
+0.00220.30%
Post-market: 0.73220.00000.00%19:50 EST
Volume:474.61K
Turnover:346.44K
Market Cap:38.44M
PE:-0.65
High:0.7400
Open:0.7276
Low:0.7061
Close:0.7300
52wk High:1.70
52wk Low:0.6150
Shares:52.50M
Float Shares:23.43M
Volume Ratio:0.57
T/O Rate:2.03%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1285
EPS(LYR):-1.0884
ROE:-908.28%
ROA:-26.26%
PB:-4.75
PE(LYR):-0.67

Loading ...

Mar 11, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 11, 2025

Major Issues Report

Form 8-K - Current report
Feb 12, 2025

Major Issues Report

Form 8-K - Current report
Jan 21, 2025

Major Issues Report

Form 8-K - Current report
Dec 19, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 07, 2024

Major Issues Report

Form 8-K - Current report
Sep 27, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Sep 13, 2024

Major Issues Report

Form 8-K - Current report
Aug 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2024

Major Issues Report

Form 8-K - Current report
Jul 31, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Jun 17, 2024

Major Issues Report

Form 8-K - Current report
Jun 13, 2024

Major Issues Report

Form 8-K - Current report
May 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 14, 2024

Major Issues Report

Form 8-K - Current report
May 03, 2024

Correspondence

Form CORRESP - Correspondence